BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 35380239)

  • 41. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
    Shah MV; Mangaonkar AA; Begna KH; Alkhateeb HB; Greipp P; Nanaa A; Elliott MA; Hogan WJ; Litzow MR; McCullough K; Tefferi A; Gangat N; Patnaik MM; Al-Kali A; He R; Chen D
    Blood Cancer J; 2022 Jul; 12(7):106. PubMed ID: 35803921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
    Diamond B; Ziccheddu B; Maclachlan K; Taylor J; Boyle E; Ossa JA; Jahn J; Affer M; Totiger TM; Coffey D; Chandhok N; Watts J; Cimmino L; Lu SX; Bolli N; Bolton K; Landau H; Park JH; Ganesh K; McPherson A; Sekeres MA; Lesokhin A; Chung DJ; Zhang Y; Ho C; Roshal M; Tyner J; Nimer S; Papaemmanuil E; Usmani S; Morgan G; Landgren O; Maura F
    Blood; 2023 May; 141(19):2359-2371. PubMed ID: 36626250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.
    Mouhieddine TH; Nzerem C; Redd R; Dunford A; Leventhal M; Sklavenitis-Pistofidis R; Tahri S; El-Khoury H; Steensma DP; Ebert BL; Soiffer RJ; Keats JJ; Mehr S; Auclair D; Ghobrial IM; Sperling AS; Stewart C; Getz G
    Cancer Res Commun; 2023 Dec; 3(12):2560-2571. PubMed ID: 38019104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
    Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
    Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutant
    Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
    JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
    Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
    Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
    Kusne Y; Fernandez J; Patnaik MM
    Semin Hematol; 2021 Oct; 58(4):226-229. PubMed ID: 34802544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations.
    Moon I; Kong MG; Ji YS; Kim SH; Park SK; Suh J; Jang MA
    Ann Lab Med; 2023 Mar; 43(2):145-152. PubMed ID: 36281508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia.
    Tahri S; Mouhieddine TH; Redd R; Lampe L; Nilsson KI; El-Khoury H; Su NK; Nassar AH; Adib E; Bindra G; Abou Alaiwi S; Trippa L; Steensma DP; Castillo JJ; Treon SP; Ghobrial IM; Sperling AS
    Blood Adv; 2022 Apr; 6(7):2230-2235. PubMed ID: 34847227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
    Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS
    Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Next generation sequencing in therapy-related myeloid neoplasms compared to
    Claerhout H; Vranckx H; Lierman E; Michaux L; Boeckx N
    Acta Clin Belg; 2022 Jun; 77(3):658-663. PubMed ID: 34197279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.
    Nowakowska MK; Kim T; Thompson MT; Bolton KL; Deswal A; Lin SH; Scheet P; Wehner MR; Nead KT
    Am J Hematol; 2022 Apr; 97(4):411-420. PubMed ID: 35015316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer.
    Lee KS; Lee CK; Kwon SS; Kwon WS; Park S; Lee ST; Choi JR; Rha SY; Shin S
    Clin Chem Lab Med; 2024 Jan; 62(1):178-186. PubMed ID: 37435889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
    Barbui T; Gavazzi A; Sciatti E; Finazzi MC; Ghirardi A; Carioli G; Carobbio A
    Curr Hematol Malig Rep; 2023 Aug; 18(4):105-112. PubMed ID: 37221411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations.
    Mangaonkar AA; Patnaik MM
    Am J Hematol; 2023 Jun; 98(6):951-964. PubMed ID: 36938794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.